nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—Vismodegib—skin cancer	0.137	0.193	CbGbCtD
Rivaroxaban—CYP3A4—Imiquimod—skin cancer	0.119	0.167	CbGbCtD
Rivaroxaban—CYP3A4—Temozolomide—skin cancer	0.119	0.167	CbGbCtD
Rivaroxaban—CYP3A4—Vismodegib—skin cancer	0.0823	0.116	CbGbCtD
Rivaroxaban—ABCB1—Dactinomycin—skin cancer	0.0721	0.101	CbGbCtD
Rivaroxaban—CYP3A4—Vemurafenib—skin cancer	0.065	0.0915	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—skin cancer	0.0572	0.0805	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—skin cancer	0.0372	0.0524	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—skin cancer	0.0223	0.0314	CbGbCtD
Rivaroxaban—CYP2J2—blood vessel—skin cancer	0.00477	0.156	CbGeAlD
Rivaroxaban—F10—nipple—skin cancer	0.00421	0.137	CbGeAlD
Rivaroxaban—CYP2J2—nipple—skin cancer	0.00345	0.113	CbGeAlD
Rivaroxaban—F10—mammalian vulva—skin cancer	0.00246	0.0802	CbGeAlD
Rivaroxaban—CYP2J2—skin of body—skin cancer	0.00221	0.0721	CbGeAlD
Rivaroxaban—F10—female reproductive system—skin cancer	0.00211	0.0687	CbGeAlD
Rivaroxaban—CYP2J2—mammalian vulva—skin cancer	0.00202	0.0657	CbGeAlD
Rivaroxaban—F10—head—skin cancer	0.00176	0.0574	CbGeAlD
Rivaroxaban—CYP2J2—female reproductive system—skin cancer	0.00173	0.0563	CbGeAlD
Rivaroxaban—CYP2J2—head—skin cancer	0.00144	0.047	CbGeAlD
Rivaroxaban—F10—lymph node—skin cancer	0.00123	0.0402	CbGeAlD
Rivaroxaban—Vomiting—Vismodegib—skin cancer	0.00108	0.00417	CcSEcCtD
Rivaroxaban—Rash—Vismodegib—skin cancer	0.00107	0.00413	CcSEcCtD
Rivaroxaban—Dermatitis—Vismodegib—skin cancer	0.00107	0.00413	CcSEcCtD
Rivaroxaban—Back pain—Imiquimod—skin cancer	0.00106	0.00409	CcSEcCtD
Rivaroxaban—Blood bilirubin increased—Docetaxel—skin cancer	0.00105	0.00408	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Fluorouracil—skin cancer	0.00105	0.00406	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Vemurafenib—skin cancer	0.00105	0.00405	CcSEcCtD
Rivaroxaban—Infection—Vemurafenib—skin cancer	0.00104	0.00402	CcSEcCtD
Rivaroxaban—Nervous system disorder—Vemurafenib—skin cancer	0.00103	0.00397	CcSEcCtD
Rivaroxaban—Skin disorder—Vemurafenib—skin cancer	0.00102	0.00393	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Imiquimod—skin cancer	0.00101	0.00392	CcSEcCtD
Rivaroxaban—Nausea—Vismodegib—skin cancer	0.00101	0.00389	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.001	0.00388	CcSEcCtD
Rivaroxaban—Osteoarthritis—Fluorouracil—skin cancer	0.001	0.00388	CcSEcCtD
Rivaroxaban—Angioedema—Imiquimod—skin cancer	0.000999	0.00386	CcSEcCtD
Rivaroxaban—Malaise—Imiquimod—skin cancer	0.000986	0.00381	CcSEcCtD
Rivaroxaban—Syncope—Imiquimod—skin cancer	0.00098	0.00379	CcSEcCtD
Rivaroxaban—Hypotension—Vemurafenib—skin cancer	0.000978	0.00378	CcSEcCtD
Rivaroxaban—Loss of consciousness—Imiquimod—skin cancer	0.000961	0.00372	CcSEcCtD
Rivaroxaban—Haematuria—Bleomycin—skin cancer	0.000948	0.00367	CcSEcCtD
Rivaroxaban—Chest pain—Imiquimod—skin cancer	0.000931	0.0036	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000924	0.00358	CcSEcCtD
Rivaroxaban—Discomfort—Imiquimod—skin cancer	0.00092	0.00356	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000919	0.00355	CcSEcCtD
Rivaroxaban—Dry mouth—Imiquimod—skin cancer	0.00091	0.00352	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000903	0.00349	CcSEcCtD
Rivaroxaban—Fatigue—Vemurafenib—skin cancer	0.000902	0.00349	CcSEcCtD
Rivaroxaban—Haemoglobin—Bleomycin—skin cancer	0.000897	0.00347	CcSEcCtD
Rivaroxaban—Constipation—Vemurafenib—skin cancer	0.000895	0.00346	CcSEcCtD
Rivaroxaban—ABCB1—blood vessel—skin cancer	0.000893	0.0291	CbGeAlD
Rivaroxaban—Oedema—Imiquimod—skin cancer	0.000892	0.00345	CcSEcCtD
Rivaroxaban—Haemorrhage—Bleomycin—skin cancer	0.000892	0.00345	CcSEcCtD
Rivaroxaban—Infection—Imiquimod—skin cancer	0.000886	0.00343	CcSEcCtD
Rivaroxaban—Shock—Imiquimod—skin cancer	0.000878	0.0034	CcSEcCtD
Rivaroxaban—Nervous system disorder—Imiquimod—skin cancer	0.000875	0.00338	CcSEcCtD
Rivaroxaban—Tachycardia—Imiquimod—skin cancer	0.000871	0.00337	CcSEcCtD
Rivaroxaban—Skin disorder—Imiquimod—skin cancer	0.000867	0.00335	CcSEcCtD
Rivaroxaban—Agranulocytosis—Dactinomycin—skin cancer	0.000865	0.00335	CcSEcCtD
Rivaroxaban—Angina pectoris—Fluorouracil—skin cancer	0.000844	0.00326	CcSEcCtD
Rivaroxaban—Infestation NOS—Temozolomide—skin cancer	0.000838	0.00324	CcSEcCtD
Rivaroxaban—Infestation—Temozolomide—skin cancer	0.000838	0.00324	CcSEcCtD
Rivaroxaban—Hepatitis—Dactinomycin—skin cancer	0.000832	0.00322	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000831	0.00322	CcSEcCtD
Rivaroxaban—Swelling—Docetaxel—skin cancer	0.00082	0.00317	CcSEcCtD
Rivaroxaban—Urinary tract infection—Temozolomide—skin cancer	0.000815	0.00315	CcSEcCtD
Rivaroxaban—Dyspnoea—Imiquimod—skin cancer	0.000796	0.00308	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Temozolomide—skin cancer	0.000793	0.00307	CcSEcCtD
Rivaroxaban—Erythema multiforme—Dactinomycin—skin cancer	0.000787	0.00304	CcSEcCtD
Rivaroxaban—Sinusitis—Temozolomide—skin cancer	0.000787	0.00304	CcSEcCtD
Rivaroxaban—Dyspepsia—Imiquimod—skin cancer	0.000785	0.00304	CcSEcCtD
Rivaroxaban—Infestation—Fluorouracil—skin cancer	0.000772	0.00299	CcSEcCtD
Rivaroxaban—Infestation NOS—Fluorouracil—skin cancer	0.000772	0.00299	CcSEcCtD
Rivaroxaban—Hypersensitivity—Vemurafenib—skin cancer	0.000771	0.00298	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Imiquimod—skin cancer	0.00077	0.00298	CcSEcCtD
Rivaroxaban—Fatigue—Imiquimod—skin cancer	0.000769	0.00298	CcSEcCtD
Rivaroxaban—Pain—Imiquimod—skin cancer	0.000763	0.00295	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Docetaxel—skin cancer	0.000757	0.00293	CcSEcCtD
Rivaroxaban—Haemoglobin—Temozolomide—skin cancer	0.000756	0.00293	CcSEcCtD
Rivaroxaban—Haemorrhage—Temozolomide—skin cancer	0.000753	0.00291	CcSEcCtD
Rivaroxaban—Hepatitis—Temozolomide—skin cancer	0.000753	0.00291	CcSEcCtD
Rivaroxaban—Urinary tract infection—Fluorouracil—skin cancer	0.000751	0.0029	CcSEcCtD
Rivaroxaban—Asthenia—Vemurafenib—skin cancer	0.000751	0.0029	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Temozolomide—skin cancer	0.000743	0.00288	CcSEcCtD
Rivaroxaban—Pruritus—Vemurafenib—skin cancer	0.00074	0.00286	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Temozolomide—skin cancer	0.00074	0.00286	CcSEcCtD
Rivaroxaban—Urethral disorder—Temozolomide—skin cancer	0.000738	0.00285	CcSEcCtD
Rivaroxaban—Feeling abnormal—Imiquimod—skin cancer	0.000735	0.00284	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Imiquimod—skin cancer	0.00073	0.00282	CcSEcCtD
Rivaroxaban—Epistaxis—Fluorouracil—skin cancer	0.000729	0.00282	CcSEcCtD
Rivaroxaban—Sinusitis—Fluorouracil—skin cancer	0.000725	0.0028	CcSEcCtD
Rivaroxaban—Pain in extremity—Docetaxel—skin cancer	0.000724	0.0028	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000724	0.0028	CcSEcCtD
Rivaroxaban—Agranulocytosis—Fluorouracil—skin cancer	0.000721	0.00279	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Bleomycin—skin cancer	0.000721	0.00279	CcSEcCtD
Rivaroxaban—Anaemia—Bleomycin—skin cancer	0.000718	0.00278	CcSEcCtD
Rivaroxaban—Diarrhoea—Vemurafenib—skin cancer	0.000716	0.00277	CcSEcCtD
Rivaroxaban—Erythema multiforme—Temozolomide—skin cancer	0.000712	0.00275	CcSEcCtD
Rivaroxaban—Urticaria—Imiquimod—skin cancer	0.000709	0.00274	CcSEcCtD
Rivaroxaban—Abdominal pain—Imiquimod—skin cancer	0.000705	0.00273	CcSEcCtD
Rivaroxaban—Eye disorder—Temozolomide—skin cancer	0.000703	0.00272	CcSEcCtD
Rivaroxaban—Malaise—Bleomycin—skin cancer	0.0007	0.00271	CcSEcCtD
Rivaroxaban—Cardiac disorder—Temozolomide—skin cancer	0.000699	0.0027	CcSEcCtD
Rivaroxaban—Haemoglobin—Fluorouracil—skin cancer	0.000697	0.0027	CcSEcCtD
Rivaroxaban—Haemorrhage—Fluorouracil—skin cancer	0.000693	0.00268	CcSEcCtD
Rivaroxaban—Dizziness—Vemurafenib—skin cancer	0.000692	0.00268	CcSEcCtD
Rivaroxaban—Angiopathy—Temozolomide—skin cancer	0.000683	0.00264	CcSEcCtD
Rivaroxaban—Immune system disorder—Temozolomide—skin cancer	0.00068	0.00263	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Temozolomide—skin cancer	0.000678	0.00262	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dactinomycin—skin cancer	0.000672	0.0026	CcSEcCtD
Rivaroxaban—Anaemia—Dactinomycin—skin cancer	0.00067	0.00259	CcSEcCtD
Rivaroxaban—Vomiting—Vemurafenib—skin cancer	0.000665	0.00257	CcSEcCtD
Rivaroxaban—Chest pain—Bleomycin—skin cancer	0.000661	0.00256	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Docetaxel—skin cancer	0.000661	0.00256	CcSEcCtD
Rivaroxaban—Rash—Vemurafenib—skin cancer	0.00066	0.00255	CcSEcCtD
Rivaroxaban—Dermatitis—Vemurafenib—skin cancer	0.000659	0.00255	CcSEcCtD
Rivaroxaban—Hypersensitivity—Imiquimod—skin cancer	0.000657	0.00254	CcSEcCtD
Rivaroxaban—Headache—Vemurafenib—skin cancer	0.000655	0.00254	CcSEcCtD
Rivaroxaban—Discomfort—Bleomycin—skin cancer	0.000653	0.00253	CcSEcCtD
Rivaroxaban—Malaise—Dactinomycin—skin cancer	0.000653	0.00253	CcSEcCtD
Rivaroxaban—Asthenia—Imiquimod—skin cancer	0.00064	0.00248	CcSEcCtD
Rivaroxaban—Oedema—Bleomycin—skin cancer	0.000634	0.00245	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Bleomycin—skin cancer	0.000634	0.00245	CcSEcCtD
Rivaroxaban—Back pain—Temozolomide—skin cancer	0.000634	0.00245	CcSEcCtD
Rivaroxaban—Pruritus—Imiquimod—skin cancer	0.000631	0.00244	CcSEcCtD
Rivaroxaban—Infection—Bleomycin—skin cancer	0.00063	0.00244	CcSEcCtD
Rivaroxaban—Nausea—Vemurafenib—skin cancer	0.000621	0.0024	CcSEcCtD
Rivaroxaban—Diarrhoea—Imiquimod—skin cancer	0.000611	0.00236	CcSEcCtD
Rivaroxaban—Discomfort—Dactinomycin—skin cancer	0.000609	0.00236	CcSEcCtD
Rivaroxaban—Angina pectoris—Docetaxel—skin cancer	0.000609	0.00236	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Temozolomide—skin cancer	0.000608	0.00235	CcSEcCtD
Rivaroxaban—Anaemia—Temozolomide—skin cancer	0.000606	0.00234	CcSEcCtD
Rivaroxaban—Angioedema—Temozolomide—skin cancer	0.000599	0.00232	CcSEcCtD
Rivaroxaban—Hypotension—Bleomycin—skin cancer	0.000592	0.00229	CcSEcCtD
Rivaroxaban—Oedema—Dactinomycin—skin cancer	0.000591	0.00229	CcSEcCtD
Rivaroxaban—Malaise—Temozolomide—skin cancer	0.000591	0.00229	CcSEcCtD
Rivaroxaban—Dizziness—Imiquimod—skin cancer	0.00059	0.00228	CcSEcCtD
Rivaroxaban—Infection—Dactinomycin—skin cancer	0.000587	0.00227	CcSEcCtD
Rivaroxaban—Vomiting—Imiquimod—skin cancer	0.000567	0.00219	CcSEcCtD
Rivaroxaban—Dyspnoea—Bleomycin—skin cancer	0.000565	0.00219	CcSEcCtD
Rivaroxaban—Rash—Imiquimod—skin cancer	0.000563	0.00218	CcSEcCtD
Rivaroxaban—Dermatitis—Imiquimod—skin cancer	0.000562	0.00217	CcSEcCtD
Rivaroxaban—Headache—Imiquimod—skin cancer	0.000559	0.00216	CcSEcCtD
Rivaroxaban—Anaemia—Fluorouracil—skin cancer	0.000558	0.00216	CcSEcCtD
Rivaroxaban—Infestation—Docetaxel—skin cancer	0.000558	0.00216	CcSEcCtD
Rivaroxaban—Infestation NOS—Docetaxel—skin cancer	0.000558	0.00216	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000554	0.00214	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000553	0.00214	CcSEcCtD
Rivaroxaban—Discomfort—Temozolomide—skin cancer	0.000551	0.00213	CcSEcCtD
Rivaroxaban—Renal failure—Docetaxel—skin cancer	0.000548	0.00212	CcSEcCtD
Rivaroxaban—Dry mouth—Temozolomide—skin cancer	0.000546	0.00211	CcSEcCtD
Rivaroxaban—Jaundice—Docetaxel—skin cancer	0.000543	0.0021	CcSEcCtD
Rivaroxaban—Pain—Bleomycin—skin cancer	0.000542	0.0021	CcSEcCtD
Rivaroxaban—Oedema—Temozolomide—skin cancer	0.000535	0.00207	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Temozolomide—skin cancer	0.000535	0.00207	CcSEcCtD
Rivaroxaban—Infection—Temozolomide—skin cancer	0.000531	0.00205	CcSEcCtD
Rivaroxaban—Nausea—Imiquimod—skin cancer	0.00053	0.00205	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Docetaxel—skin cancer	0.000527	0.00204	CcSEcCtD
Rivaroxaban—Epistaxis—Docetaxel—skin cancer	0.000526	0.00203	CcSEcCtD
Rivaroxaban—Nervous system disorder—Temozolomide—skin cancer	0.000524	0.00203	CcSEcCtD
Rivaroxaban—Feeling abnormal—Bleomycin—skin cancer	0.000522	0.00202	CcSEcCtD
Rivaroxaban—Agranulocytosis—Docetaxel—skin cancer	0.00052	0.00201	CcSEcCtD
Rivaroxaban—Skin disorder—Temozolomide—skin cancer	0.000519	0.00201	CcSEcCtD
Rivaroxaban—Chest pain—Fluorouracil—skin cancer	0.000514	0.00199	CcSEcCtD
Rivaroxaban—Fatigue—Dactinomycin—skin cancer	0.00051	0.00197	CcSEcCtD
Rivaroxaban—Discomfort—Fluorouracil—skin cancer	0.000508	0.00196	CcSEcCtD
Rivaroxaban—Pain—Dactinomycin—skin cancer	0.000506	0.00196	CcSEcCtD
Rivaroxaban—Urticaria—Bleomycin—skin cancer	0.000504	0.00195	CcSEcCtD
Rivaroxaban—Haemoglobin—Docetaxel—skin cancer	0.000503	0.00195	CcSEcCtD
Rivaroxaban—Hepatitis—Docetaxel—skin cancer	0.000501	0.00194	CcSEcCtD
Rivaroxaban—Haemorrhage—Docetaxel—skin cancer	0.000501	0.00194	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Docetaxel—skin cancer	0.000494	0.00191	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Fluorouracil—skin cancer	0.000493	0.00191	CcSEcCtD
Rivaroxaban—Oedema—Fluorouracil—skin cancer	0.000493	0.00191	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Docetaxel—skin cancer	0.000492	0.0019	CcSEcCtD
Rivaroxaban—Urethral disorder—Docetaxel—skin cancer	0.000491	0.0019	CcSEcCtD
Rivaroxaban—Infection—Fluorouracil—skin cancer	0.000489	0.00189	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dactinomycin—skin cancer	0.000487	0.00188	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dactinomycin—skin cancer	0.000483	0.00187	CcSEcCtD
Rivaroxaban—Nervous system disorder—Fluorouracil—skin cancer	0.000483	0.00187	CcSEcCtD
Rivaroxaban—Tachycardia—Fluorouracil—skin cancer	0.000481	0.00186	CcSEcCtD
Rivaroxaban—Dyspnoea—Temozolomide—skin cancer	0.000477	0.00184	CcSEcCtD
Rivaroxaban—Erythema multiforme—Docetaxel—skin cancer	0.000473	0.00183	CcSEcCtD
Rivaroxaban—Dyspepsia—Temozolomide—skin cancer	0.000471	0.00182	CcSEcCtD
Rivaroxaban—Eye disorder—Docetaxel—skin cancer	0.000468	0.00181	CcSEcCtD
Rivaroxaban—Abdominal pain—Dactinomycin—skin cancer	0.000467	0.00181	CcSEcCtD
Rivaroxaban—Hypersensitivity—Bleomycin—skin cancer	0.000467	0.00181	CcSEcCtD
Rivaroxaban—Cardiac disorder—Docetaxel—skin cancer	0.000465	0.0018	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Temozolomide—skin cancer	0.000462	0.00179	CcSEcCtD
Rivaroxaban—Fatigue—Temozolomide—skin cancer	0.000461	0.00178	CcSEcCtD
Rivaroxaban—Hypotension—Fluorouracil—skin cancer	0.00046	0.00178	CcSEcCtD
Rivaroxaban—Pain—Temozolomide—skin cancer	0.000457	0.00177	CcSEcCtD
Rivaroxaban—Constipation—Temozolomide—skin cancer	0.000457	0.00177	CcSEcCtD
Rivaroxaban—CYP3A4—female reproductive system—skin cancer	0.000456	0.0149	CbGeAlD
Rivaroxaban—Asthenia—Bleomycin—skin cancer	0.000455	0.00176	CcSEcCtD
Rivaroxaban—Angiopathy—Docetaxel—skin cancer	0.000454	0.00176	CcSEcCtD
Rivaroxaban—Immune system disorder—Docetaxel—skin cancer	0.000452	0.00175	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Docetaxel—skin cancer	0.000451	0.00174	CcSEcCtD
Rivaroxaban—Pruritus—Bleomycin—skin cancer	0.000448	0.00173	CcSEcCtD
Rivaroxaban—Feeling abnormal—Temozolomide—skin cancer	0.000441	0.0017	CcSEcCtD
Rivaroxaban—Dyspnoea—Fluorouracil—skin cancer	0.000439	0.0017	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Temozolomide—skin cancer	0.000437	0.00169	CcSEcCtD
Rivaroxaban—Hypersensitivity—Dactinomycin—skin cancer	0.000436	0.00168	CcSEcCtD
Rivaroxaban—ABCB1—epithelium—skin cancer	0.000435	0.0142	CbGeAlD
Rivaroxaban—Dyspepsia—Fluorouracil—skin cancer	0.000434	0.00168	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000425	0.00165	CcSEcCtD
Rivaroxaban—Urticaria—Temozolomide—skin cancer	0.000425	0.00164	CcSEcCtD
Rivaroxaban—Asthenia—Dactinomycin—skin cancer	0.000424	0.00164	CcSEcCtD
Rivaroxaban—Abdominal pain—Temozolomide—skin cancer	0.000423	0.00164	CcSEcCtD
Rivaroxaban—Back pain—Docetaxel—skin cancer	0.000421	0.00163	CcSEcCtD
Rivaroxaban—Pain—Fluorouracil—skin cancer	0.000421	0.00163	CcSEcCtD
Rivaroxaban—Muscle spasms—Docetaxel—skin cancer	0.000419	0.00162	CcSEcCtD
Rivaroxaban—Feeling abnormal—Fluorouracil—skin cancer	0.000406	0.00157	CcSEcCtD
Rivaroxaban—Diarrhoea—Dactinomycin—skin cancer	0.000405	0.00156	CcSEcCtD
Rivaroxaban—Vomiting—Bleomycin—skin cancer	0.000403	0.00156	CcSEcCtD
Rivaroxaban—Anaemia—Docetaxel—skin cancer	0.000403	0.00156	CcSEcCtD
Rivaroxaban—Rash—Bleomycin—skin cancer	0.0004	0.00155	CcSEcCtD
Rivaroxaban—Dermatitis—Bleomycin—skin cancer	0.000399	0.00154	CcSEcCtD
Rivaroxaban—Hypersensitivity—Temozolomide—skin cancer	0.000394	0.00152	CcSEcCtD
Rivaroxaban—Urticaria—Fluorouracil—skin cancer	0.000391	0.00151	CcSEcCtD
Rivaroxaban—Syncope—Docetaxel—skin cancer	0.000391	0.00151	CcSEcCtD
Rivaroxaban—Asthenia—Temozolomide—skin cancer	0.000384	0.00148	CcSEcCtD
Rivaroxaban—Loss of consciousness—Docetaxel—skin cancer	0.000383	0.00148	CcSEcCtD
Rivaroxaban—Pruritus—Temozolomide—skin cancer	0.000378	0.00146	CcSEcCtD
Rivaroxaban—ABCB1—mammalian vulva—skin cancer	0.000377	0.0123	CbGeAlD
Rivaroxaban—Nausea—Bleomycin—skin cancer	0.000377	0.00146	CcSEcCtD
Rivaroxaban—Vomiting—Dactinomycin—skin cancer	0.000376	0.00145	CcSEcCtD
Rivaroxaban—Rash—Dactinomycin—skin cancer	0.000373	0.00144	CcSEcCtD
Rivaroxaban—Chest pain—Docetaxel—skin cancer	0.000371	0.00143	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000368	0.00142	CcSEcCtD
Rivaroxaban—Diarrhoea—Temozolomide—skin cancer	0.000366	0.00142	CcSEcCtD
Rivaroxaban—Hypersensitivity—Fluorouracil—skin cancer	0.000363	0.0014	CcSEcCtD
Rivaroxaban—Dry mouth—Docetaxel—skin cancer	0.000363	0.0014	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Docetaxel—skin cancer	0.000356	0.00138	CcSEcCtD
Rivaroxaban—Oedema—Docetaxel—skin cancer	0.000356	0.00138	CcSEcCtD
Rivaroxaban—Dizziness—Temozolomide—skin cancer	0.000354	0.00137	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—skin cancer	0.000353	0.00137	CcSEcCtD
Rivaroxaban—Nausea—Dactinomycin—skin cancer	0.000351	0.00136	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—skin cancer	0.00035	0.00135	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—skin cancer	0.000349	0.00135	CcSEcCtD
Rivaroxaban—Pruritus—Fluorouracil—skin cancer	0.000349	0.00135	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—skin cancer	0.000347	0.00134	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—skin cancer	0.000345	0.00134	CcSEcCtD
Rivaroxaban—Vomiting—Temozolomide—skin cancer	0.00034	0.00132	CcSEcCtD
Rivaroxaban—Rash—Temozolomide—skin cancer	0.000337	0.0013	CcSEcCtD
Rivaroxaban—Diarrhoea—Fluorouracil—skin cancer	0.000337	0.0013	CcSEcCtD
Rivaroxaban—Dermatitis—Temozolomide—skin cancer	0.000337	0.0013	CcSEcCtD
Rivaroxaban—Headache—Temozolomide—skin cancer	0.000335	0.0013	CcSEcCtD
Rivaroxaban—ABCB1—lymphoid tissue—skin cancer	0.000335	0.0109	CbGeAlD
Rivaroxaban—Hypotension—Docetaxel—skin cancer	0.000332	0.00129	CcSEcCtD
Rivaroxaban—Dizziness—Fluorouracil—skin cancer	0.000326	0.00126	CcSEcCtD
Rivaroxaban—ABCB1—female reproductive system—skin cancer	0.000323	0.0105	CbGeAlD
Rivaroxaban—Nausea—Temozolomide—skin cancer	0.000318	0.00123	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—skin cancer	0.000317	0.00123	CcSEcCtD
Rivaroxaban—Vomiting—Fluorouracil—skin cancer	0.000313	0.00121	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—skin cancer	0.000313	0.00121	CcSEcCtD
Rivaroxaban—Rash—Fluorouracil—skin cancer	0.000311	0.0012	CcSEcCtD
Rivaroxaban—Dermatitis—Fluorouracil—skin cancer	0.00031	0.0012	CcSEcCtD
Rivaroxaban—Headache—Fluorouracil—skin cancer	0.000309	0.00119	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—skin cancer	0.000307	0.00119	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—skin cancer	0.000307	0.00119	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—skin cancer	0.000304	0.00118	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—skin cancer	0.000304	0.00118	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—skin cancer	0.000293	0.00113	CcSEcCtD
Rivaroxaban—Nausea—Fluorouracil—skin cancer	0.000293	0.00113	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—skin cancer	0.000291	0.00112	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—skin cancer	0.000281	0.00109	CcSEcCtD
Rivaroxaban—ABCB1—head—skin cancer	0.00027	0.00879	CbGeAlD
Rivaroxaban—Hypersensitivity—Docetaxel—skin cancer	0.000262	0.00101	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—skin cancer	0.000255	0.000987	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—skin cancer	0.000252	0.000973	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—skin cancer	0.000243	0.000941	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—skin cancer	0.000235	0.00091	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—skin cancer	0.000226	0.000875	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—skin cancer	0.000224	0.000867	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—skin cancer	0.000224	0.000866	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—skin cancer	0.000223	0.000862	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—skin cancer	0.000211	0.000817	CcSEcCtD
Rivaroxaban—ABCB1—lymph node—skin cancer	0.000189	0.00616	CbGeAlD
